Chronic Eosinophilic Leukemia Positive for FIP1L1-PDGFRa

<i>FIP1L1-PDGFRα-</i>positive chronic eosinophilic leukemia (CEL) is a rare subtype of myeloproliferative neoplasm characterized by organ damage caused by eosinophilic granules containing cytokines and humoral factors. These include interleukin-5 (IL-5), interleukin-4 (IL-4), and interleukin-13 (IL-13). We present a case study of a 71-year-old male who initially presented with cough, fever, night sweats, and weight loss. Fluorescence in situ hybridization (FISH) and cytogenetic testing confirmed that the patient had <i>FIP1L1-PDGFRα-</i>positive chronic eosinophilic leukemia. Treatment with imatinib and prednisone led to a rapid decrease in the eosinophil count without further damage from eosinophilic infiltration. Our patient has tolerated therapy with occasional lightheadedness that he attributed to external factors, and he continues to remain in remission. This case study aims to contribute to the existing knowledge regarding the discovery and treatment of this disease.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-02-24
DOI
https://doi.org/10.7759/cureus.79548
Citations
1
Primary Topic
Eosinophilic Disorders and Syndromes
Type
article
Field-Weighted Citation Impact
1.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chronic Eosinophilic Leukemia Positive for FIP1L1-PDGFRa

David Ross, Borys Hrinczenko, STEVEN HAYDON, Shane Clark et al.
1 citations
Cureus
Eosinophilic Disorders and Syndromes
1.67
article

Chronic Eosinophilic Leukemia Positive for FIP1L1-PDGFRa

David Ross, Borys Hrinczenko, STEVEN HAYDON, Shane Clark, Stephen Caucci
article en
1 citations

Abstract

<i>FIP1L1-PDGFRα-</i>positive chronic eosinophilic leukemia (CEL) is a rare subtype of myeloproliferative neoplasm characterized by organ damage caused by eosinophilic granules containing cytokines and humoral factors. These include interleukin-5 (IL-5), interleukin-4 (IL-4), and interleukin-13 (IL-13). We present a case study of a 71-year-old male who initially presented with cough, fever, night sweats, and weight loss. Fluorescence in situ hybridization (FISH) and cytogenetic testing confirmed that the patient had <i>FIP1L1-PDGFRα-</i>positive chronic eosinophilic leukemia. Treatment with imatinib and prednisone led to a rapid decrease in the eosinophil count without further damage from eosinophilic infiltration. Our patient has tolerated therapy with occasional lightheadedness that he attributed to external factors, and he continues to remain in remission. This case study aims to contribute to the existing knowledge regarding the discovery and treatment of this disease.

CureusVol. 17(2)
Michigan State University (US)
Good health and well-being
Openalex Percentile: Top 20%
Eosinophilic Disorders and Syndromes
1.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.